Cargando…
Non-small cell lung cancer: the new T1 categories
Recently, major changes have occurred in the staging, diagnosis, and treatment of early stage lung cancer. By screening high-risk populations, we are now able to detect lung cancers at an early stage, but the false-positive rate is high. A new pathological classification was published in 2011 and fu...
Autor principal: | Van Schil, Paul E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
F1000Research
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5325065/ https://www.ncbi.nlm.nih.gov/pubmed/28299198 http://dx.doi.org/10.12688/f1000research.10600.1 |
Ejemplares similares
-
Diagnosis and treatment of non-small cell lung cancer: current advances and challenges
por: Diebels, Ian, et al.
Publicado: (2022) -
Operable non-small cell lung cancer: induction therapy, adjuvant therapy, or both?
por: Agrafiotis, Apostolos C., et al.
Publicado: (2023) -
Surgical Management of Stage IIIA Non-Small Cell Lung Cancer
por: Van Schil, Paul E., et al.
Publicado: (2017) -
Surgical treatment of early-stage non-small-cell lung cancer
por: Van Schil, Paul E., et al.
Publicado: (2013) -
Minimally Invasive Surgery in Non-Small Cell Lung Cancer: Where Do We Stand?
por: Berzenji, Lawek, et al.
Publicado: (2023)